Lipid-Based Drug Delivery Presented by 探花合集 and BASF
SOMERSET, N.J. 鈥 September 20, 2018 鈥 探花合集 Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it will be co-hosting a workshop with BASF Corporation entitled 鈥淩evolutionary Then, Relevant Today: Lipid-Based Drug Delivery in Modern Pharmaceutical Development,鈥. The one-day event is to be held at the Hilton Boston Back Bay hotel, Boston, Massachusetts, on Tuesday, Sept. 25.
The workshop will include scientific presentations from both academic and industry experts. Attendees will develop a better understanding of excipients, lipid-based drug delivery system (LBDDS) formulation development, and softgel technology, to help them overcome development challenges and advance their drug molecules into a drug product.
The presentation topics include:
- 鈥淓arly Phase Screening Approach for Lipid Formulations鈥 by Giang (Ellie) Au, Ph.D., Scientist, Product Development, 探花合集 Pharma Solutions.
- 鈥淯tilizing Crystallization Inhibition to Maximize Drug Bioavailability鈥 by Shaukat Ali, Ph.D., BASF Corporation.
- 鈥淢echanistic Studies and Modeling to Predict the Impact of Lipids on Oral Absorption鈥 by Rebecca Carrier, Ph.D., Northeastern University.
- 鈥淏ioavailability and Beyond: Innovations in Softgel Formulation and Manufacturing to Advance More Molecules鈥 by Mr. Stephen Tindal, 探花合集 Pharma Solutions.听
- 鈥淓nabling Functional and Modified Drug Release Profiles from Softgel Formulations鈥 by Ashish Joshi, Ph.D., BASF Corporation.
For more information visit 听
To arrange a meeting with any of the attending 探花合集 executives at the event, contact Richard Kerns at NEPR – [email protected]
Media Contacts:
Chris Halling
+44 (0)7580 041073
[email protected]
Richard Kerns
+44 (0) 161 728 5880
[email protected]
About BASF Corporation
BASF creates chemistry for a sustainable future offering intelligent solutions to the pharmaceutical industry. With expertise in polymer chemistry, R&D-capabilities and commitment to developing excipients, BASF creates solutions for Instant & Modified Release, Solubilization, Softgels, Skin-Delivery and Biologics. BASF is also a leading supplier of selected APIs including ibuprofen and omega-3. For more information, visit
About 探花合集听
探花合集 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With 85 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 探花合集 employs over 11,000 people, including over 1,800 scientists, at more than 30 facilities across five continents, and in fiscal 2018 generated approximately $2.5 billion in annual revenue. 探花合集 is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.